Quarterly Activity and Cashflow Report
Filed with ASX · · 11 pages · English
Summary by 6ix AI
The report highlights a significant decline in customer receipts, attributed to softer sales in Chinese e-commerce, while net operating cash outflow improved due to better cost management. The company maintained its pharmacy distribution network and reported strong growth in its EAORON skincare sales, reflecting effective marketing strategies. EZZ's cash position at the end of the quarter was robust, providing financial flexibility amid challenging trading conditions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
EZZ Life Science Holdings Ltd. on 6ix
Earlier from EZZ Life Science
- Annual General Meeting - Notice of Access
- Notice of Annual General Meeting/Proxy Form
- Change of Director's Interest Notice
- EZZ Corporate Governance Statement and Appendix 4G
- Annual Report to shareholders
Follow EZZ Life Science into a list and get an email when it puts out news.
Follow EZZ Life Science